+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Next Generation Sequencing"

From
Oligonucleotide Synthesis - Global Strategic Business Report - Product Thumbnail Image

Oligonucleotide Synthesis - Global Strategic Business Report

  • Report
  • March 2025
  • 194 Pages
  • Global
From
Nucleic Acid Labeling - Global Strategic Business Report - Product Thumbnail Image

Nucleic Acid Labeling - Global Strategic Business Report

  • Report
  • March 2025
  • 179 Pages
  • Global
From
From
Genotyping - Global Strategic Business Report - Product Thumbnail Image

Genotyping - Global Strategic Business Report

  • Report
  • March 2025
  • 193 Pages
  • Global
From
Genomics - Global Strategic Business Report - Product Thumbnail Image

Genomics - Global Strategic Business Report

  • Report
  • March 2025
  • 292 Pages
  • Global
From
Human Identification - Global Strategic Business Report - Product Thumbnail Image

Human Identification - Global Strategic Business Report

  • Report
  • March 2025
  • 196 Pages
  • Global
From
NGS-Based RNA-Sequencing - Global Strategic Business Report - Product Thumbnail Image

NGS-Based RNA-Sequencing - Global Strategic Business Report

  • Report
  • March 2025
  • 196 Pages
  • Global
From
Gene Panel - Global Strategic Business Report - Product Thumbnail Image

Gene Panel - Global Strategic Business Report

  • Report
  • March 2025
  • 197 Pages
  • Global
From
Bioburden Testing - Global Strategic Business Report - Product Thumbnail Image

Bioburden Testing - Global Strategic Business Report

  • Report
  • March 2025
  • 173 Pages
  • Global
From
From
Epigenetics - Global Strategic Business Report - Product Thumbnail Image

Epigenetics - Global Strategic Business Report

  • Report
  • March 2025
  • 427 Pages
  • Global
From
Molecular Cytogenetics - Global Strategic Business Report - Product Thumbnail Image

Molecular Cytogenetics - Global Strategic Business Report

  • Report
  • March 2025
  • 657 Pages
  • Global
From
From
Molecular Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Molecular Diagnostics - Global Strategic Business Report

  • Report
  • March 2025
  • 880 Pages
  • Global
From
Genetic Testing - Global Strategic Business Report - Product Thumbnail Image

Genetic Testing - Global Strategic Business Report

  • Report
  • March 2025
  • 573 Pages
  • Global
From
Biochips - Global Strategic Business Report - Product Thumbnail Image

Biochips - Global Strategic Business Report

  • Report
  • March 2025
  • 369 Pages
  • Global
From
MiRNA Sequencing and Assays - Global Strategic Business Report - Product Thumbnail Image

MiRNA Sequencing and Assays - Global Strategic Business Report

  • Report
  • February 2025
  • 465 Pages
  • Global
From
Biotechnology Reagents - Global Strategic Business Report - Product Thumbnail Image

Biotechnology Reagents - Global Strategic Business Report

  • Report
  • February 2025
  • 232 Pages
  • Global
From
Next Generation Sequencers - Global Strategic Business Report - Product Thumbnail Image

Next Generation Sequencers - Global Strategic Business Report

  • Report
  • February 2025
  • 299 Pages
  • Global
From
Loading Indicator

The Next Generation Sequencing (NGS) market is a subset of the biotechnology industry that focuses on the development and application of high-throughput sequencing technologies. NGS technologies enable the rapid and cost-effective sequencing of large amounts of DNA or RNA, allowing for the analysis of genetic variation and gene expression. This technology has been used to identify and characterize genetic mutations, to study gene expression, and to develop new diagnostics and therapeutics. NGS has also been used to study the evolution of viruses and bacteria, and to identify new species. The NGS market is highly competitive, with a number of companies offering a range of sequencing technologies and services. Some of the major players in the market include Illumina, Thermo Fisher Scientific, BGI, Pacific Biosciences, Oxford Nanopore Technologies, and 10x Genomics. Show Less Read more